From April 13, 2023 to June 30, 2023, the company has repurchased 158,983 shares, representing 1.08% for $4.23 million. With this, the company has completed the repurchase of 158,983 shares, representing 1.08% for $4.23 million under the buyback announced on April 13, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26 USD | +0.08% |
|
-1.07% | +14.74% |
May. 30 | Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics | CI |
May. 28 | Anika Therapeutics Approves $40 Million Share Repurchase Program | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.74% | 386M | |
+2.22% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on April 13, 2023.